Vanguard Personalized Indexing Management LLC Purchases 462 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Vanguard Personalized Indexing Management LLC grew its position in Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 7.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,354 shares of the biotechnology company’s stock after acquiring an additional 462 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in Axon Enterprise were worth $1,843,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Avantax Advisory Services Inc. boosted its holdings in Axon Enterprise by 0.8% during the 1st quarter. Avantax Advisory Services Inc. now owns 5,302 shares of the biotechnology company’s stock valued at $1,659,000 after acquiring an additional 40 shares during the period. Brookstone Capital Management boosted its stake in shares of Axon Enterprise by 5.1% during the first quarter. Brookstone Capital Management now owns 839 shares of the biotechnology company’s stock valued at $263,000 after purchasing an additional 41 shares during the period. CWM LLC grew its holdings in shares of Axon Enterprise by 1.5% in the second quarter. CWM LLC now owns 2,820 shares of the biotechnology company’s stock worth $830,000 after purchasing an additional 43 shares during the last quarter. Wealthspan Partners LLC increased its stake in Axon Enterprise by 4.9% in the 2nd quarter. Wealthspan Partners LLC now owns 965 shares of the biotechnology company’s stock worth $284,000 after buying an additional 45 shares during the period. Finally, Burns Matteson Capital Management LLC lifted its holdings in Axon Enterprise by 6.7% during the 2nd quarter. Burns Matteson Capital Management LLC now owns 730 shares of the biotechnology company’s stock valued at $215,000 after buying an additional 46 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $393.29 on Friday. The company has a market capitalization of $29.72 billion, a PE ratio of 115.00, a P/E/G ratio of 10.34 and a beta of 0.94. The company has a 50-day simple moving average of $348.04 and a two-hundred day simple moving average of $317.22. Axon Enterprise, Inc. has a one year low of $189.12 and a one year high of $393.58. The company has a debt-to-equity ratio of 0.35, a quick ratio of 2.52 and a current ratio of 2.88.

Axon Enterprise (NASDAQ:AXONGet Free Report) last posted its quarterly earnings data on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, topping the consensus estimate of $1.02 by $0.18. The firm had revenue of $504.00 million during the quarter, compared to analyst estimates of $478.35 million. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. Axon Enterprise’s revenue was up 34.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.80 EPS. Research analysts expect that Axon Enterprise, Inc. will post 1.79 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have commented on AXON shares. Robert W. Baird upped their target price on shares of Axon Enterprise from $360.00 to $400.00 and gave the stock an “outperform” rating in a research note on Tuesday, September 10th. Bank of America began coverage on Axon Enterprise in a research note on Wednesday, July 17th. They issued a “buy” rating and a $380.00 price objective on the stock. Needham & Company LLC reaffirmed a “buy” rating and set a $400.00 target price on shares of Axon Enterprise in a research report on Wednesday, August 7th. JMP Securities increased their price target on Axon Enterprise from $375.00 to $430.00 and gave the stock an “outperform” rating in a research report on Thursday, September 12th. Finally, Northland Securities lifted their price objective on Axon Enterprise from $330.00 to $365.00 and gave the company an “outperform” rating in a report on Thursday, August 8th. Two analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $365.38.

Check Out Our Latest Analysis on Axon Enterprise

Insider Transactions at Axon Enterprise

In other news, Director Matthew R. Mcbrady sold 2,000 shares of the firm’s stock in a transaction on Friday, August 9th. The stock was sold at an average price of $364.66, for a total value of $729,320.00. Following the completion of the sale, the director now owns 4,892 shares of the company’s stock, valued at approximately $1,783,916.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director Matthew R. Mcbrady sold 2,000 shares of Axon Enterprise stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $364.66, for a total value of $729,320.00. Following the completion of the sale, the director now directly owns 4,892 shares in the company, valued at approximately $1,783,916.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Patrick W. Smith sold 80,300 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the sale, the chief executive officer now directly owns 3,015,366 shares in the company, valued at approximately $1,121,052,771.48. The disclosure for this sale can be found here. Over the last three months, insiders have sold 317,981 shares of company stock valued at $115,662,734. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

See Also

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.